These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 4247466)

  • 1. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis: kinetics of the lysis of a fibrin clot].
    Daver J; Edmond E; Panak E; Ricoeur M
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):333-42. PubMed ID: 4246032
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP; Ferguson JH
    Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 6. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Variation of plasminemia during experimental thrombolysis].
    Courbier R; Vairel E; Josserand JM; Bourgade P; Henry E
    Presse Med (1893); 1969 Oct; 77(41):1427-8. PubMed ID: 4242099
    [No Abstract]   [Full Text] [Related]  

  • 8. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M; Abildgaard U
    Thromb Diath Haemorrh; 1971 Jun; 25(3):580-9. PubMed ID: 4998018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Post-mortem fibrinolysis in man].
    Harms D
    Veroff Morphol Pathol; 1971; 87():1-74. PubMed ID: 5144656
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement during fibrinolytic therapy.
    McNicol GP
    Proc R Soc Med; 1969 Nov; 62(11 Part 1):1131-3. PubMed ID: 5356869
    [No Abstract]   [Full Text] [Related]  

  • 11. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

  • 12. [Micromethod for simultaneous determination of retraction, spontaneous fibrinolysis, and hemostatic properties of blood clots].
    Bandarin VA; Ivanov EP; Siatkovskiĭ VA; Trusov LN
    Lab Delo; 1971; 12():716-20. PubMed ID: 4111441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 14. A new method based on one dimensional diffusion using small glass tubes for the measurement of fibrinolytic activity. I. Fibrinolytic activity of plasmin and "euglobulin + streptokinase".
    Yasukouchi T; Watanabe T
    Thromb Diath Haemorrh; 1972 Dec; 28(3):329-41. PubMed ID: 4265315
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of some synthetic compounds on in vitro fibrinolytic activity measured by different methods and the relevance to activity in vivo.
    Baillie AJ; Sim AK
    Thromb Diath Haemorrh; 1972 Dec; 28(3):351-8. PubMed ID: 4265316
    [No Abstract]   [Full Text] [Related]  

  • 17. [The determination of serum fibrinolytic inhibitors by the fibrin plate method].
    Daver J; Albugues MJ; Du Pasquier JP; Ricoeur M
    Ann Biol Clin (Paris); 1969; 27(10):721-33. PubMed ID: 5374300
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A; Vermylen J; Verstraete M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):7-19. PubMed ID: 4189377
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.